April 13, 2021 13:05 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
India surpasses Brazil with 1.35 crore overall cases of Covid-19 | Kerala's vaccine stocks will last only three more days: CM Pinarayi Vijayan writes to Centre | Haryana govt imposes night curfew amid steep rise in Covid cases | Bengal polls: ECI bans Mamata Banerjee from campaigning for 24 hours starting 8 pm tonight | Sushil Chandra to take over as new Chief Election Commissioner from tomorrow

Serum Institute seeks financial assistance from govt to boost capacity

New Delhi/IBNS: Adar Poonawalla, the CEO of world's largest vaccine manufacturer Serum Institute of India (SII), has told NDTV it needs Rs 3,000 crore in assistance from the Indian government to expand its production capacity which is currently "very stretched" in wake of the export restrictions imposed by the government last month.

India's COVID-19 vaccine diplomacy shines in South Asia and beyond

New Delhi: India's vaccine diplomacy seems to be shining as the country is giving millions of doses of COVID-19 vaccine to South Asian nations for the past few days, promising to help its neighbours, among others, at a time when the disease continues to grip the region. Now it is spreading beyond the regional boundaries as well.

Pune: 5 killed in fire at Serum Institute's under-construction facility

Pune/IBNS: At least five people have been killed in the fire which broke out at an under-construction facility of India's biotechnology and pharmaceuticals company Serum Institute of India (SII) here on Thursday.

Fire breaks out at Serum Institute's under-construction facility in Pune

Pune/IBNS: A fire broke out at an under-construction facility of India's biotechnology and pharmaceuticals company Serum Institute of India (SII) here on Thursday.

'Will file Rs. 100 cr defamation suit': Serum Institute after vaccine trial participant claims to fall ill

Pune/IBNS: The Serum Institute of India (SII), which has developed the Oxford vaccine to treat Novel Coronavirus in the country, said it would slap a defamation suit of Rs. 100 crore against an individual who claimed to have fallen ill after taking a dose of Covid-19 vaccine during the trial, media reports said.